Assess whether regulatory approval is a timing risk or a deal risk (09b2a4)

SITUATION A public acquirer facing HSR and sector regulators cannot treat an HSR second-request rumor as incidental context on regulatory-approval critical-path calendar. Customer-contract risk reviewer must close regulatory approval is a from that extract under M&A Due Diligence / People and Contracts.

DECISION Customer-contract risk reviewer in a public acquirer facing HSR and sector regulators must choose Regulatory approval is a timing risk / A deal risk using regulatory-approval critical-path calendar after an HSR second-request rumor.

HYPOTHESES TO TEST 1. The population in regulatory-approval critical-path calendar is the one an HSR second-request rumor named, so Regulatory approval is a timing risk follows for this People and Contracts file. 2. The population in regulatory-approval critical-path calendar is adjacent only to an HSR second-request rumor; A deal risk is the honest M&A Due Diligence call. 3. A public acquirer facing HSR and sector regulators already contained an HSR second-request rumor before regulatory-approval critical-path calendar arrived; no new People and Contracts path. 4. Provenance on regulatory-approval critical-path calendar after an HSR second-request rumor is broken; do not pick Regulatory approval is a timing risk or A deal risk yet.

ANALYSIS REQUIRED 1. Name the document customer-contract risk reviewer still needs before signing. 2. Test whether an HSR second-request rumor is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 4. For this M&A Due Diligence People and Contracts file, read regulatory-approval critical-path calendar against an HSR second-request rumor and write the one fact that would move regulatory approval is a for customer-contract risk reviewer.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / People and Contracts packet (regulatory-approval critical-path calendar after an HSR second-request rumor). The follow-on People and Contracts action is what customer-contract risk reviewer does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in regulatory-approval critical-path calendar, then the action for customer-contract risk reviewer - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - People and Contracts finding in regulatory-approval critical-path calendar that a second reviewer can re-perform - Missing page in regulatory-approval critical-path calendar after an HSR second-request rumor, if any